Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease

Neurobiology of Aging

Volumn 33, Issue 1, 2012, Pages 206.e29-206.e39

  Polito, Cristina ^a   Berti, Valentina ^a   Ramat, Silvia ^a   Vanzi, Eleonora ^a   De Cristofaro, Maria Teresa ^a   Pellicanò, Giannantonio ^a   Mungai, Francesco ^a   Marini, Paolo ^a   Formiconi, Andreas Robert ^a   Sorbi, Sandro ^a   Pupi, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Basal ganglia; Cognitive functions; FDG PET; FP CIT SPECT; Parkinson's disease

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOFLUPANE I 123;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; BRAIN METABOLISM; CAUDATE NUCLEUS; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; DOPAMINE METABOLISM; FEMALE; FRONTOSTRIATAL CIRCUIT; HUMAN; IN VIVO STUDY; LANGUAGE ABILITY; MALE; MENTAL PERFORMANCE; NERVE TRACT; ORBITAL CORTEX; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 81355141954     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.09.004     Document Type: Article

References (67)

1. Aarsland D., Brønnick K., Larsen J.P., Tysnes O.B., Alves G. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 2009, 72:1121-1126. Norwegian ParkWest Study Group.
2. Alexander G.E., Chen K., Pietrini P., Rapoport S.I., Reiman E.M. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am. J. Psychiatry 2002, 159:738-745.
3. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990, 13:266-271.
4. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci 1986, 9:357-381.
5. Baddeley A.D. Exploring the central executive. Q. J. Exp. Psych. 1996, 49A:5-28.
6. Berger H.J., Cools A.R., Horstink M.W., Oyen W.J., Verhoeven E.W., van der Werf S.P. Striatal dopamine and learning strategy-an (123)I-FP-CIT SPECT study. Neuropsychologia 2004, 42:1071-1078.
7. Berti V., Polito C., Ramat S., Vanzi E., De Cristofaro M.T., Pellicanò G., Mungai F., Marini P., Formiconi A.R., Sorbi S., Pupi A. Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease. Eur. J. Nucl. Med. Mol. Imaging 2010, 37:537-544.
8. Berti V., Pupi A., Ramat S., Vanzi E., De Cristofaro M.T., Pellicanò G., Mungai F., Marini P., Sorbi S. Clinical correlation of the binding potential with 123I-FP-CIT in de novo idiopathic Parkinson's disease patients. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:2220-2226.
9. 123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur. J. Nucl. Med 2001, 28:266-272.
10. Booij J., Tissingh G., Boer G.J., Speelman J.D., Stoof J.C., Janssen A.G., Wolters E.C., van Royen E.A. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1997, 62:133-140.
11. Broussolle E., Dentresangle C., Landais P., Garcia-Larrea L., Pollak P., Croisile B., Hibert O., Bonnefoi F., Galy G., Froment J.C., Comar D. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease. J. Neurol. Sci 1999, 166:141-151.
12. Brück A., Aalto S., Nurmi E., Bergman J., Rinne J.O. Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease. Neurobiol. Aging 2005, 26:891-898.
13. Brück A., Portin R., Lindell A., Laihinen A., Bergman J., Haaparanta M., Solin O., Rinne J.O. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucelus. Neurosci. Lett. 2001, 311:81-84.
14. Caffarra P., Vezzadini G., Dieci F., Zonato F., Venneri A. Una versione abbreviata del test di Stroop: dati normativi nella popolazione italiana. (A brief version of the Stroop test: normative data in the Italian population.). Nuova Riv. Neurol. 2002, 12:111-115.
15. Caffarra P., Vezzadini G., Dieci F., Zonato F., Venneri A. Modified Card Sorting Test: normative data. J. Clin. Exp. Neuropsychol 2004, 26:246-250.
16. Carlin D., Bonerba J., Phipps M., Alexander G., Shapiro M., Grafman J. Planning impairments in frontal lobe dementia and frontal lobe lesion patients. Neuropsychologia 2000, 38:655-665.
17. Caviness J.N., Driver-Dunckley E., Connor D.J., Sabbagh M.N., Hentz J.G., Noble B., Evidente V.G., Shill H.A., Adler C.H. Defining mild cognitive impairment in Parkinson's disease. Mov. Disord 2007, 22:1272-1277.
18. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci. Biobehav. Rev 2006, 30:1-23.
19. Crawford J.R., Henry J.D. Assessment of executive deficits. The Effectiveness of Rehabilitation for Cognitive Deficits 2005, 233-246. Oxford University Press, London. P.W. Halligan, N. Wade (Eds.).
20. Dubois B., Burn D., Goetz C., Aarsland D., Brown R.G., Broe G.A., Dickson D., Duyckaerts C., Cummings J., Gauthier S., Korczyn A., Lees A., Levy R., Litvan I., Mizuno Y., McKeith I.G., Olanow C.W., Poewe W., Sampaio C., Tolosa E., Emre M. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov. Disord 2007, 22:2314-2324.
21. Duchesne N., Soucy J.P., Masson H., Chouinard S., Bédard M.A. Cognitive deficits and striatal dopaminergic denervation in Parkinson's disease: a single photon emission computed tomography study using 123iodine-beta-CIT in patients on and off levodopa. Clin. Neuropharmacol. 2002, 25:216-224.
22. Fahn S., Elton R.L. Unified Parkinson's disease rating scale. Recent Developments in Parkinson's Disease 1987, 153-164. members of the UPDRS Development Committee, Macmillan Healthcare information, Florham Park. S. Fahn, C.D. Marsden, D.B. Calne, M. Goldstein (Eds.).
23. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114:2283-2301.
24. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res 1975, 12:189-198.
25. Formiconi A.R. Least squares algorithm for region of interest evaluation in emission tomography. IEEE Trans. Med. Imaging 1993, 12:90-100.
26. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol 1999, 56:33-39.
27. Freedman M., Black S., Ebert P., Binns M. Orbitofrontal function, object alternation and perseveration. Cereb. Cortex 1998, 8:18-27.
28. Freedman M. Object alternation and orbitofrontal system dysfunction in Alzheimer's and Parkinson's disease. Brain Cogn. 1990, 14:134-143.
29. Goodglass H., Kaplan E. Assessment of cognitive deficit in the brain-injured patient. Handbook of Behavioral Neurology 1979, Vol. 2:3-22. Plenum Press, New York. M.S. Gazzaniga (Ed.).
30. Grahn J.A., Parkinson J.A., Owen A.M. The cognitive functions of the caudate nucleus. Prog. Neurobiol 2008, 86:141-155.
31. Greve K.W., Love J.M., Sherwin E., Mathias C.W., Ramzinski P., Levy J. Wisconsin Card Sorting Test in chronic severe traumatic brain injury: Factor structure and performance subgroups. Brain Inj. 2002, 16:29-40.
32. Henry J.D., Crawford J.R. Verbal fluency deficits in Parkinson's disease: a meta-analysis. J. Int. Neuropsychol. Soc 2004, 10:608-622.
33. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
34. Jokinen P., Brück A., Aalto S., Forsback S., Parkkola R., Rinne J.O. Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat. Disord. 2009, 15:88-93.
35. Huang C., Mattis P., Perrine K., Brown N., Dhawan V., Eidelberg D. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 2008, 70:1470-1477.
36. Huang C., Mattis P., Tang C., Perrine K., Carbon M., Eidelberg D. Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage 2007, 34:714-723.
37. Kish S.J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J. Med 1988, 318:876-880.
38. Lehericy S., Ducros M., Van de Moortele P.F., Francois C., Thivard L., Poupon C., Swindale N., Ugurbil K., Kim D.S. Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans. Ann. Neurol 2004, 55:522-529.
39. Lozza C., Baron J.C., Eidelberg D., Mentis M.J., Carbon M., Marié R.M. Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum. Brain Mapp. 2004, 22:236-245.
40. Marie R.M., Barre L., Dupuy B., Viader F., Defer G., Baron J.C. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci. Lett 1999, 260:77-80.
41. MacLeod C.M. Half a century of research on the Stroop effect: An integrative review. Psychol. Bull 1991, 109:163-203.
42. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003, 19:1233-1239.
43. Measso G., Cavarzeran F., Zappalà G., Lebowitz B.D., Crook T.H., Pirozzolo F.J., Amaducci L.A., Massari D., Grigoletto F. Il Mini Mental State Examination: studio normativo di un campione random della popolazione italiana. (Mini Mental State Examination: a normative study on a randomized sample of the Italian population.). Dev. Neuropsychol. 1993, 9:77-85.
44. Miyake A., Friedman N.P., Emerson M.J., Witzki A.H., Howerter A., Wager T.D. The unity and diversity of executive functions and their contributions to complex "frontal lobe" tasks: A latent variable analysis. Cognit. Psych 2000, 41:49-100.
45. Monchi O., Petrides M., Doyon J., Postuma R.B., Worsley K., Dagher A. Neural bases of set-shifting deficits in Parkinson's disease. J. Neurosci 2004, 24:702-710.
46. Müller U., Wächter T., Barthel H., Reuter M., von Cramon D.Y. Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease. J. Neural Transm. 2000, 107:303-319.
47. Muslimović D., Post B., Speelman J.D., Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005, 65:1239-1245.
48. Nandhagopal R., McKeown M.J., Stoessl A.J. Functional imaging in Parkinson disease. Neurology 2008, 70:1478-1488.
49. Nelson H.E. A modified card sorting test sensitive to frontal lobe deficits. Cortex 1976, 12:313-324.
50. Obeso J.A., Marin C., Rodriguez-Oroz C., Blesa J., Benitez-Temiño B., Mena-Segovia J., Rodríguez M., Olanow C.W. The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Ann. Neurol. 2008, 64:S30-S46.
51. Owen A.M. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. Neuroscientist 2004, 10:525-537.
52. Parsons T.D., Rogers S.A., Braaten A.J., Woods S.P., Tröster A.I. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol. 2006, 5:578-588.
53. Pérez-Otaño I., Oset C., Luquin M.R., Herrero M.T., Obeso J.A., Del Río J. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration. Neurosci. Lett. 1994, 175:121-125.
54. Postuma R.B., Dagher A. Basal ganglia functional connectivity based on a meta-analysis of 126 positron emission tomography and functional magnetic resonance imaging publications. Cereb. Cortex 2006, 16:1508-1521.
55. Riedel O., Klotsche J., Spottke A., Deuschl G., Forstl H., Henn F., Heuser I., Oertel W., Reichmann H., Riederer P., Trenkwalder C., Dodel R., Wittchen H.U. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J. Neurol 2008, 255:255-264.
56. Rinne J.O., Portin R., Ruottinen H., Nurmi E., Bergman J., Haaparanta M., Solin O. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch. Neurol 2000, 57:470-475.
57. Rinne J.O., Rummukainen J., Paljarvi L., Rinne U.K. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann. Neurol 1989, 26:47-50.
58. Spinnler H., Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. (Italian standardization of neuropsychological tests.). Ital. J. Neurol. Sci. suppl 1987, 8:1-120.
59. Stuss D.T., Levine B. Adult clinical neuropsychology: Lessons from studies of the frontal lobes. Annu. Review Psych 2002, 53:401-433.
60. Talairach J., Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain 1988, Thieme, New York.
61. Talmi D., Grady C.L., Goshen-Gottstein Y., Moscovitch M. Neuroimaging the serial position curve. A test of single-store versus dual-store models. Psychol. Sci 2005, 16:716-723.
62. Vanzi E., De Cristofaro M.T., Ramat S., Sotgia B., Mascalchi M., Formiconi A.R. A direct ROI quantification method for inherent PVE correction: accuracy assessment in striatal SPECT measurements. Eur. J. Nucl. Med. Mol. Imaging 2007, 34:1480-1489.
63. Whittington C.J., Podd J., Stewart-Williams S. Memory deficits in Parkinson's disease. J. Clin. Exp. Neuropsychol 2006, 28:738-754.
64. Williams-Gray C.H., Foltynie T., Brayne C.E.G., Robbins T.W., Barker R.A. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007, 130:1787-1798.
65. Winogrodzka A., Bergmans P., Booij J., van Royen E.A., Stoof J.C., Wolters E.C. [(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2003, 74:294-298.
66. Yeterian E.H., Pandya D.N. Prefrontostriatal connections in relation to cortical architectonic organization in rhesus monkeys. J. Comp. Neurol 1991, 312:43-67.
67. Zgaljardic D.J., Borod J.C., Foldi N.S., Mattis P.J., Gordon M.F., Feigin A., Eidelberg D. An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. J. Clin. Exp. Neuropsychol 2006, 28:1127-1144.